In addition, PPARγ activation promotes the expression of its target gene PTEN to inhibit the PI3K/AKT/mTOR signaling, thereby suppressing the proliferation of breast cancer cells and the tumorigenicity and metastasis of cervical, glioblastoma, and liver cancer stem cells.52 This evidence concerns the gene PTEN and breast carcinoma.